- Home
- MDGL vs CHRD Comparison
MDGL vs CHRD Comparison
Compare MDGL & CHRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MDGL | CHRD |
|---|---|---|
| Founded | 2011 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8B | 8.2B |
| IPO Year | 2005 | 2010 |
Fundamental Metrics
Financial Performance| Metric | MDGL | CHRD |
|---|---|---|
| Price | $521.80 | $156.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 13 |
| Target Price | ★ $674.45 | $149.17 |
| AVG Volume (30 Days) | 205.9K | ★ 604.4K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 3.56% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 11.14 |
| Revenue | ★ $180,133,000.00 | N/A |
| Revenue This Year | $58.39 | $12.56 |
| Revenue Next Year | $48.55 | N/A |
| P/E Ratio | ★ N/A | $13.64 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $393.61 | $84.25 |
| 52 Week High | $615.00 | $154.00 |
Technical Indicators
Market Signals| Indicator | MDGL | CHRD |
|---|---|---|
| Relative Strength Index (RSI) | 53.63 | 62.47 |
| Support Level | $529.02 | $129.88 |
| Resistance Level | $546.29 | N/A |
| Average True Range (ATR) | 17.75 | 4.26 |
| MACD | 0.13 | 0.04 |
| Stochastic Oscillator | 73.75 | 71.96 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
About CHRD Chord Energy Corporation
Chord Energy Corp is an independent exploration and production (E&P) company engaged in the acquisition, exploration, development and production of crude oil, NGL and natural gas prominently in the Williston Basin, with limited non-operated interests in the Marcellus Shale. It operates in one reportable business segment, which is the E&P of crude oil, NGL and natural gas. The company derives revenue from the sale of crude oil, NGL and natural gas production.